Genetic and immunological markers in pouchitis

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 10, 1996, Pages 951-955

  Brett, Peter M ^a   Yasuda, Naukuni ^b   Yiannakou, John Y ^a   Herbst, Frederick ^b   Ellis, H Julia ^a   Vaughan, Robert ^a   Nicholls, R John ^b   Ciclitira, Paul J ^a,c  

^a G   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

HLA class II; Interleukin 1 receptor antagonist; p ANCA; Pouchitis

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; BIOPSY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HISTOLOGY; HLA SYSTEM; HUMAN; ILEITIS; ILEUM POUCH; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; TANDEM REPEAT; ULCERATIVE COLITIS;

EID: 0029972168     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199610000-00003     Document Type: Article

References (30)

1. Nicholls RJ: Pouchitis - what's new in aetiology and management. Can J Gastroenterol 1995, 9:17-22.
2. Ambrose WL, Pemberton JH, Phillips SF, Bell AM, Haddad AC: Faecal short chain fatty acid concentrations and effect on ileal pouch function. Dis Colon Rectum 1993, 36:235-239.
3. Breuer NF, Rampton DS, Tammar A, Murphy CM, Dowling RH: Effect of colonic perfusion with sulphated and non-sulphated bile acids on mucosal structure and function in the rat. Gastroenterology 1983, 84:969-977.
4. Fleshman JW, Cohen Z, McLeod RS, Stern H, Blair J: The ileal reservoir and ileoanal anastomosis procedure. Factors affecting technical and functional outcome. Dis Colon Rectum 1988, 31:10-16.
5. Orholm M, Munkholm P, Langholtz E, Neilsen OH, Sorensen TIA, Binder V: Familial occurrence of inflammatory bowel disease. N Engl J Med 1991, 324:84-88.
6. Orholm M, Iselius L, Sorensen TIA, Munkholm P, Langholtz E, Binder V: Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ 1993, 306:20-24.
7. Satsangi J, Welsh KI, Bunce M, Bell JI, Jewell DP: Class II HLA genes in inflammatory bowel disease: evidence for a relationship between genotype and disease phenotype. Clin Sci 1994, 88:43p.
8. Satsangi J, Welsh KI, Bunce M, Bell JI, Jewell DP: HLA class II genes are important determinants of disease susceptibility in ulcerative colitis, but not in Crohn's disease. Gut 1995, 37(suppl. 2):T84.
9. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, et al.: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994, 106:637-642.
10. Roussomoustakaki M, Louis E, Satsangi J, Mortensen NJM, Kettlewell MGW, Jewell DP: Cytokine gene polymorphisms in patients with an ileal pouch anal anastomosis (IPAA) for ulcerative colitis. Gut 1995, 37(suppl. 2):W59.
11. Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol 1995, 154:2434-2440.
12. Targan S, Saxon A, Landers C, Ganz T, Shanahan F: Serum anti-neutrophil cytoplasmic antibodies distinguish ulcerative colitis from Crohn's disease patients. Gastroenterology 1989, 96:A505.
13. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of anti-neutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990, 86:202-210.
14. Sandborn WJ, Landers CJ, Tremaine WJ: The presence of neutrophil cytoplasmic antibody correlates with pouchitis after ileal pouch-anal anastomosis for ulcerative colitis. Gastroenterology 1993, 104:A774.
15. Vecchi M, Gionchetti P, Bianchi MB: P-ANCA reactivity in ulcerative colitis patients with and without pouchitis after colectomy. Gastroenterology 1993, 104:A796.
16. Oudkerk Pool M, Ellerbroek PM, Rindwan BU, Goldschmeding R, Vonblomberg BMF, Pena AS et al.: Serum anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic antibodies and clinical parameters, medical and surgical treatment. Gut 1993, 34:46-50.
17. Firestein CS, Boyle DL, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP: Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994, 37:644-652.
18. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al.: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 base pair tandem repeat. Hum Genet 1993, 91:403-404.
19. Clay FE, Cork MJ, Tarlow JK, Blakemore AIF, Harrington CI, Lewis F, et al.: Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosis. Hum Genet 1994, 94:407-410.
20. Blakemore AIF, Watson PF, Weetman AP, Duff GW: Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995, 80:111-115.
21. Moskowilz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986, 1:167-174.
22. Olerup O, Aldener A, Fogdell A: HLA-DQβ1 and DQα1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993, 41:119-134.
23. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1993, 39:225-235.
24. Wilk A. Delineation of standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989, 97(suppl. 6):12-13.
25. Lock RJ. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol 1994, 47:4-8.
26. Cominelli F, Nast CC, Clark BD, Schindler R, Llerena R, Eysselein VE, et al.: Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990, 86:972-980.
27. Dinarello CA, Thompson RC: Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991, 12:404-410.
28. Yang H, Rotter JI, Toyoda H, Landers C, Tyan D, McElree CK, et al.: Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993, 92:1080-1084.
29. Yang P, Järnerot C, Danielsson D, Tysk C, Lindberg E. P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995, 36:887-890.
30. Doherty DG, Vaughan RW, Donaldson PT, Mowat AP: HLA DQA, DQB and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British Caucasoids. Hum Immunol 1992, 34:53-63.